OrganiGram Holdings
(NASDAQ:OGI)
$1.78
-0.02[-1.11%]
At close: May 10
$1.78
0[0.00%]
After Hours: 4:44PM EDT
Q2 2024 earnings tomorrow on Tue May 14th before the market open
Conference call scheduled tomorrow at 8:00 AM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

OrganiGram Holdings Stock (NASDAQ:OGI), Quotes and News Summary

OrganiGram Holdings Stock (NASDAQ: OGI) stock price, news, charts, stock research, profile.

Open$1.830
Close$1.760
Volume / Avg.722.789K / 1.586M
Day Range1.740 - 1.830
52 Wk Range0.970 - 2.910
Market Cap$183.338M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
42
Short Interest
5.49%
Days to Cover1.53

Recent News

No Cannabis Tax Relief In Canada, Tilray CEO Says This 'Hinders Our Ability To Compete With The Illicit Market'
Nina Zdinjak
EXCLUSIVE: Fifteen New F1 Hybrid Cannabis Strains To Hit Shelves In US For 4/20 Under New Partnership
California-based I Love Growing Marijuana (ILGM), announced on Tuesday an exclusive new partnership with cannabis genetics and breeding company, Phylos Bioscience, that brings 15 new F1 hybrid strains to home growers across legal markets nationwide. ILGM is launching half the collection of strains that are "crafted for potency, flavor, and diversity" on its website just in time for marijuana culture's high holiday on 4/20. In doing so, the company is leveraging Phylos Bioscience's cutting-edge technology and extensive genetic library, which Benzinga has learned exclusively. Ernst Rustenhoven, CEO of ILGM, commented on the new partnership. "ILGM caters to a customer base of novice and veteran home growers on the hunt for increasingly unique strains of superior genetics, and we have been seeking an innovative partner to help elevate and diversify our product offerings," Rustenhoven said. "In forging a relationship with Phylos, we are taking our seed catalog to the next level with a highly curated selection of sought-after F1 hybrid strains."
Jelena Martinovic
NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?
The Canadian cannabis sector is witnessing a notable upswing, driven by recent developments including Tilray's (NASDAQ: TLRY) earnings report, Organigram's investor day (NASDAQ: OGI) and pivotal movements by Canopy Growth (NASDAQ:
Nicolás Jose Rodriguez
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
OGI

FAQ

Q

How do I buy OrganiGram Holdings (OGI) stock?

A

You can purchase shares of OrganiGram Holdings (NASDAQ: OGI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are OrganiGram Holdings's (OGI) competitors?

A

There are no as such competitors for OrganiGram Holdings.

Q

What is the target price for OrganiGram Holdings (OGI) stock?

A

The latest price target for OrganiGram Holdings (NASDAQ: OGI) was reported by Stifel on Monday, July 17, 2023. The analyst firm set a price target for 4.00 expecting OGI to rise to within 12 months (a possible 124.72% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for OrganiGram Holdings (OGI)?

A

The stock price for OrganiGram Holdings (NASDAQ: OGI) is $1.78 last updated May 10, 2024 at 4:44 PM EDT.

Q

Does OrganiGram Holdings (OGI) pay a dividend?

A

There are no upcoming dividends for OrganiGram Holdings.

Q

When is OrganiGram Holdings (NASDAQ:OGI) reporting earnings?

A

OrganiGram Holdings’s Q3 earnings are confirmed for Thursday, July 11, 2024.

Q

Is OrganiGram Holdings (OGI) going to split?

A

There is no upcoming split for OrganiGram Holdings.

Q

What sector and industry does OrganiGram Holdings (OGI) operate in?

A

OrganiGram Holdings is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.